The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Directing Transition from Innate to Acquired Immunity: Defining a Role for IL-6
Open accessAbstract
Appropriate control of leukocyte recruitment and activation is a fundamental requirement for competent host defense and resolving inflammation. A pivotal event that defines the successful outcome of any inflammatory event is the transition from innate to acquired immunity. In IL-6 deficiency, this process appears defective, and a series of in vivo studies have documented important roles for IL-6 in both the resolution of innate immunity and the development of acquired immune responses. Within this review, particular attention will be given to the regulatory properties of the soluble IL-6 receptor and how its activity may affect chronic disease progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Principles of interleukin (IL)-6-type cytokine signalling and its regulation
HEINRICH, P. C., BEHRMANN, I., HAAN, S., HERMANNS, H. M., MÜLLER-NEWEN, G., & SCHAPER, F. (2003) · Biochemical Journal · doi:10.1042/bj20030407 · Cited by 3,272 · cited 2×
“signaling, the reader is referred elsewhere (24).”
BackgroundToll Pathway-Dependent Blockade of CD4 + CD25 + T Cell-Mediated Suppression by Dendritic Cells
Pasare, C., & Medzhitov, R. (2003) · Science · doi:10.1126/science.1078231 · Cited by 1,997
A blast from the past: clearance of apoptotic cells regulates immune responses
Savill, J., Dransfield, I., Gregory, C., & Haslett, C. (2002) · Nature Reviews Immunology · doi:10.1038/nri957 · Cited by 1,574
Xing, Z., Gauldie, J., Cox, G., Baumann, H., Jordana, M., Lei, X. F., & Achong, M. K. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1368 · Cited by 1,498
Atreya, R., Mudter, J., Finotto, S., Müllberg, J., Jostock, T., Wirtz, S., Schütz, M., Bartsch, B., Holtmann, M., Becker, C., et al. (2000) · Nature Medicine · doi:10.1038/75068 · Cited by 1,293
Interleukin-6 family of cytokines and gp130
Kishimoto, T., Akira, S., Narazaki, M., & Taga, T. (1995) · Blood · doi:10.1182/blood.v86.4.1243.bloodjournal8641243 · Cited by 1,272
Role of IL-6 and Its Soluble Receptor in Induction of Chemokines and Leukocyte Recruitment
Romano, M., Sironi, M., Toniatti, C., Polentarutti, N., Fruscella, P., Ghezzi, P., Faggioni, R., Luini, W., van Hinsbergh, V., Sozzani, S., et al. (1997) · Immunity · doi:10.1016/s1074-7613(00)80334-9 · Cited by 1,112
The interface between innate and adaptive immunity
Hoebe, K., Janssen, E., & Beutler, B. (2004) · Nature Immunology · doi:10.1038/ni1004-971 · Cited by 916
IL-6 switches the differentiation of monocytes from dendritic cells to macrophages
Chomarat, P., Banchereau, J., Davoust, J., & Karolina Palucka, A. (2000) · Nature Immunology · doi:10.1038/82763 · Cited by 906
Chemokines: immunology's high impact factors
Mackay, C. R. (2001) · Nature Immunology · doi:10.1038/84298 · Cited by 845
Tilg, H., Trehu, E., Atkins, M., Dinarello, C., & Mier, J. (1994) · Blood · doi:10.1182/blood.v83.1.113.113 · Cited by 817
IL-6: a regulator of the transition from neutrophil to monocyte recruitment during inflammation
Kaplanski, G. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(02)00013-3 · Cited by 811
Hurst, S. M., Wilkinson, T. S., McLoughlin, R. M., Jones, S., Horiuchi, S., Yamamoto, N., Rose-John, S., Fuller, G. M., Topley, N., & Jones, S. A. (2001) · Immunity · doi:10.1016/s1074-7613(01)00151-0 · Cited by 811
Self-citationInterleukin (IL)-6 directs the differentiation of IL-4-producing CD4+ T cells
Rincón, M., Anguita, J., Nakamura, T., Fikrig, E., & Flavell, R. A. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.3.461 · Cited by 810
IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages
Yasukawa, H., Ohishi, M., Mori, H., Murakami, M., Chinen, T., Aki, D., Hanada, T., Takeda, K., Akira, S., Hoshijima, M., et al. (2003) · Nature Immunology · doi:10.1038/ni938 · Cited by 771
TGF-β Suppresses Tumor Progression in Colon Cancer by Inhibition of IL-6 trans-Signaling
Becker, C., Fantini, M. C., Schramm, C., Lehr, H. A., Wirtz, S., Nikolaev, A., Burg, J., Strand, S., Kiesslich, R., Huber, S., et al. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.020 · Cited by 726
Soluble gp130 is the natural inhibitor of soluble interleukin‐6 receptor transsignaling responses
Jostock, T., Müllberg, J., Özbek, S., Atreya, R., Blinn, G., Voltz, N., Fischer, M., Neurath, M. F., & Rose‐John, S. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.01867.x · Cited by 641
Ito, H., Takazoe, M., Fukuda, Y., Hibi, T., Kusugami, K., Andoh, A., Matsumoto, T., Yamamura, T., Azuma, J., & Nishimoto, N. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.01.012 · Cited by 636
The soluble interleukin 6 receptor: mechanisms of production and implications in disease
JONES, S. A., HORIUCHI, S., TOPLEY, N., YAMAMOTO, N., & FULLER, G. M. (2001) · The FASEB Journal · doi:10.1096/fj.99-1003rev · Cited by 623
Self-citationChoy, E. H. S., Isenberg, D. A., Garrood, T., Farrow, S., Ioannou, Y., Bird, H., Cheung, N., Williams, B., Hazleman, B., Price, R., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10623 · Cited by 526 · cited 2×
“This is exemplified by the application of the blocking anti-IL-6 receptor Ab MRA (Atlizumab, Tocilizumab), which has proven highly effective in the treatment of rheumatoid arthritis and Crohn’s disease (16, 17).”
BackgroundInhibition of T cell apoptosis in the rheumatoid synovium.
Salmon, M., Scheel-Toellner, D., Huissoon, A. P., Pilling, D., Shamsadeen, N., Hyde, H., D'Angeac, A. D., Bacon, P. A., Emery, P., & Akbar, A. N. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119178 · Cited by 469
IL-6 is required for the development of Th1 cell-mediated murine colitis
Yamamoto, M., Yoshizaki, K., Kishimoto, T., & Ito, H. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.9.4878 · Cited by 411
Interleukin 6 plays a key role in the development of antigen-induced arthritis
Ohshima, S., Saeki, Y., Mima, T., Sasai, M., Nishioka, K., Nomura, S., Kopf, M., Katada, Y., Tanaka, T., Suemura, M., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8222 · Cited by 406
Apoptosis as a therapeutic tool in rheumatoid arthritis
Pope, R. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri846 · Cited by 401
Nakahara, H., Song, J., Sugimoto, M., Hagihara, K., Kishimoto, T., Yoshizaki, K., & Nishimoto, N. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11143 · Cited by 395
Yokota, S., Miyamae, T., Imagawa, T., Iwata, N., Katakura, S., Mori, M., Woo, P., Nishimoto, N., Yoshizaki, K., & Kishimoto, T. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20944 · Cited by 370
IL-6 trans-signaling via STAT3 directs T cell infiltration in acute inflammation
McLoughlin, R. M., Jenkins, B. J., Grail, D., Williams, A. S., Fielding, C. A., Parker, C. R., Ernst, M., Topley, N., & Jones, S. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501794102 · Cited by 333
Self-citationDoganci, A., Eigenbrod, T., Krug, N., De Sanctis, G. T., Hausding, M., Erpenbeck, V. J., Haddad, E.-B., Schmitt, E., Bopp, T., Kallen, K.-J., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci22433 · Cited by 333
Romani, L., Mencacci, A., Cenci, E., Spaccapelo, R., Toniatti, C., Puccetti, P., Bistoni, F., & Poli, V (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.4.1345 · Cited by 313
Doganci, A., Eigenbrod, T., Krug, N., De Sanctis, G. T., Hausding, M., Erpenbeck, V. J., Haddad, E.-B., Schmitt, E., Bopp, T., Kallen, K.-J., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522433 · Cited by 304
Rivino, L., Messi, M., Jarrossay, D., Lanzavecchia, A., Sallusto, F., & Geginat, J. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040774 · Cited by 286
McLoughlin, R. M., Witowski, J., Robson, R. L., Wilkinson, T. S., Hurst, S. M., Williams, A. S., Williams, J. D., Rose-John, S., Jones, S. A., & Topley, N. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17129 · Cited by 281
Self-citationKovalovich, K., Li, W., DeAngelis, R., Greenbaum, L. E., Ciliberto, G., & Taub, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100740200 · Cited by 280
Treatment of severe rheumatoid arthritis by anti-interleukin 6 monoclonal antibody.
Wendling, D., Racadot, E., & Wijdenes, J. (1993) · PubMed · Cited by 274
Opposing roles of STAT1 and STAT3 in T cell–mediated hepatitis: regulation by SOCS
Hong, F., Jaruga, B., Kim, W. H., Radaeva, S., El-Assal, O. N., Tian, Z., Nguyen, V.-A., & Gao, B. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15841 · Cited by 270
Nowell, M. A., Richards, P. J., Horiuchi, S., Yamamoto, N., Rose-John, S., Topley, N., Williams, A. S., & Jones, S. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.6.3202 · Cited by 268
Self-citationJones, S. A., & Rose-John, S. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(02)00319-1 · Cited by 255
Self-citationReview: IL-6 Transsignaling: The In Vivo Consequences
Jones, S. A., Richards, P. J., Scheller, J., & Rose-John, S. (2005) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2005.25.241 · Cited by 251
Self-citationIL-6 rescues resting mouse T cells from apoptosis
Teague, T. K., Marrack, P., Kappler, J. W., & Vella, A. T. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.12.5791 · Cited by 248
Cooperation between STAT3 and c-Jun Suppresses Fas Transcription
Ivanov, V. N., Bhoumik, A., Krasilnikov, M., Raz, R., Owen-Schaub, L. B., Levy, D., Horvath, C. M., & Ronai, Z. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00199-x · Cited by 248
Ulich, T. R., Yin, S., Guo, K., Yi, E. S., Remick, D. G., & del Castillo, J. M. G. (1991) · PubMed Central · Cited by 241
Atsumi, T., Ishihara, K., Kamimura, D., Ikushima, H., Ohtani, T., Hirota, S., Kobayashi, H., Park, S.-J., Saeki, Y., Kitamura, Y., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020619 · Cited by 225 · cited 1×
“Such mechanisms for evading apoptotic cell death are also evident in vivo, with development of autoimmune arthritis in mice displaying exaggerated gp130-mediated STAT3 activity being associated with an inability of T cells to enter apoptosis (51).”
BackgroundThe role of transsignalling via the agonistic soluble IL-6 receptor in human diseases
Kallen, K.-J. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(02)00325-7 · Cited by 205
Marin, V., Montero-Julian, F. A., Grès, S., Boulay, V., Bongrand, P., Farnarier, C., & Kaplanski, G. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.6.3435 · Cited by 204
Modur, V, Li, Y., Zimmerman, G. A., Prescott, S. M., & McIntyre, T. M. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119821 · Cited by 204
Protective role of interleukin 6 in the lipopolysaccharide-galactosamine septic shock model
Barton, B. E., & Jackson, J. V. (1993) · Infection and Immunity · doi:10.1128/iai.61.4.1496-1499.1993 · Cited by 200
C-reactive Protein: A Physiological Activator of Interleukin 6 Receptor Shedding
Jones, S. A., Novick, D., Horiuchi, S., Yamamoto, N., Szalai, A. J., & Fuller, G. M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.3.599 · Cited by 196
Self-citationNarimatsu, M., Maeda, H., Itoh, S., Atsumi, T., Ohtani, T., Nishida, K., Itoh, M., Kamimura, D., Park, S., Mizuno, K., et al. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.19.6615-6625.2001 · Cited by 173
Yoshizaki, K., Nishimoto, N., Mihara, M., & Kishimoto, T. (1998) · Springer Seminars in Immunopathology · doi:10.1007/bf00832010 · Cited by 164
IL-6 receptor blockage inhibits the onset of autoimmune kidney disease in NZB/W F1 mice
Mihara, M., Takagi, N., Takeda, Y., & Ohsugi, Y. (1998) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1998.00612.x · Cited by 159
Hegde, S., Pahne, J., & Smola, S. (2004) · The FASEB Journal · doi:10.1096/fj.03-0969fje · Cited by 152
McLoughlin, R. M., Hurst, S. M., Nowell, M. A., Harris, D. A., Horiuchi, S., Morgan, L. W., Wilkinson, T. S., Yamamoto, N., Topley, N., & Jones, S. A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.9.5676 · Cited by 140
Self-citationConcentrations and origins of soluble interleukin 6 receptor-alpha in serum and synovial fluid.
Desgeorges, A., Gabay, C., Silacci, P., Novick, D., Roux-Lombard, P., Grau, G. E., Dayer, J. M., VISCHER, T. L., & Guerne, P. A. (1997) · PubMed · Cited by 134
IL-6 Increases Primed Cell Expansion and Survival
Rochman, I., Paul, W. E., & Ben-Sasson, S. Z. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.8.4761 · Cited by 132
Klouche, M., Rose‐John, S., Schmiedt, W., & Bhakdi, S. (2000) · Circulation · doi:10.1161/01.cir.101.15.1799 · Cited by 125
Teague, T., Schaefer, B., Hildeman, D. A., Bender, J., Mitchell, T., Kappler, J., & Marrack, P. (2000) · Journal of Experimental Medicine · doi:10.1084/jem.191.6.915 · Cited by 115
Endogenous and Exogenous IL-6 Inhibit Aeroallergen-Induced Th2 Inflammation
Wang, J., Homer, R., Chen, Q., & Elias, J. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.7.4051 · Cited by 113
Chen, Q., Wang, W., Bruce, R., Li, H., Schleider, D. M., Mulbury, M. J., Bain, M. D., Wallace, P. K., Baumann, H., & Evans, S. S. (2004) · Immunity · doi:10.1016/s1074-7613(03)00358-3 · Cited by 110
Curnow, J., Scheel‐Toellner, D., Jenkinson, W. E., Raza, K., Durrani, O. M., Faint, J., Rauz, S., Wloka, K., Pilling, D., Rose‐John, S., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.8.5290 · Cited by 102
Role of IL-6 and the Soluble IL-6 Receptor in Inhibition of VCAM-1 Gene Expression
Oh, J., Wagoner, N. J. V., Rose‐John, S., & Benveniste, E. N. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.9.4992 · Cited by 102
Activity of interleukin 6 in the differentiation of monocytes to macrophages and dendritic cells
Mitani, H., Katayama, N., Araki, H., Ohishi, K., Kobayashi, K., Suzuki, H., Nishii, K., Masuya, M., Yasukawa, K., Minami, N., et al. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02020.x · Cited by 99
Köpf, M., Ramsay, A. J., Brombacher, F., Baumann, H., Freer, G., Galanos, C., Gutierrez-Ramos, J.-C., & Köhler, G. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb32335.x · Cited by 96
Activation of inflammation and leukocyte recruitment into the peritoneal cavity.
Topley, N., Liberek, T., Davenport, A., Li, F., Fear, H., & Williams, J. D. (1996) · PubMed · Cited by 94
Flamme, A. C. L., & Pearce, E. J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.10.5829 · Cited by 68
Diao, H., & Kohanawa, M. (2005) · Infection and Immunity · doi:10.1128/iai.73.6.3745-3748.2005 · Cited by 63
Role of IL-6 in activation of T cells for acquired cellular resistance to Listeria monocytogenes.
Liu, Z., Simpson, R. J., & Cheers, C. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.11.5375 · Cited by 61
Marin, V., Montero‐Julian, F. A., Grès, S., Bongrand, P., Farnarier, C., & Kaplanski, G. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(2002010)32:10<2965::aid-immu2965>3.0.co;2-v · Cited by 58
Matsumiya, T., Imaizumi, T., Fujimoto, K., Cui, X., Shibata, T., Tamo, W., Kumagai, M., Tanji, K., Yoshida, H., Kimura, H., et al. (2001) · Experimental Cell Research · doi:10.1006/excr.2001.5300 · Cited by 48
Jenkins, B. J., Grail, D., Inglese, M., Quilici, C., Bozinovski, S., Wong, P., & Ernst, M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.4.1453-1463.2004 · Cited by 43 · cited 2×
“However, these studies also highlight that the differentiation pathway adopted may depend on the nature of the signal transmitted via gp130, since M-CSF receptor expression is inversely related to the quality of the gp130-mediated STAT3 signal (54).”
BackgroundBleier, J. I. S., Pillarisetty, V. G., Shah, A. B., & DeMatteo, R. P. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.12.7408 · Cited by 42
Onogawa, T. (2005) · Immunobiology · doi:10.1016/j.imbio.2004.09.006 · Cited by 22
Cited by
The pro- and anti-inflammatory properties of the cytokine interleukin-6
Scheller, J., Chalaris, A., Schmidt-Arras, D., & Rose-John, S. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.01.034 · Cited by 3,212
IL-6 as a keystone cytokine in health and disease
Hunter, C. A., & Jones, S. A. (2015) · Nature Immunology · doi:10.1038/ni.3153 · Cited by 2,511
Self-citationZhang, C., Wu, Z., Li, J.-W., Zhao, H., & Wang, G.-Q. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105954 · Cited by 1,758
Innate immunity of the newborn: basic mechanisms and clinical correlates
Levy, O. (2007) · Nature Reviews Immunology · doi:10.1038/nri2075 · Cited by 1,223
Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer
Jones, S. A., & Jenkins, B. J. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0066-7 · Cited by 1,102
Self-citation
Metadata
- Authors
- Jones, S. A.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-09
- Volume
- 175
- Issue
- 6
- Pages
- 3463-3468
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1948268265
- Cited by
- 771
- References
- 71
- FWCI
- 15.69
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.